MN HF3143

Establishes emergency insulin assistance program administered by commissioner of administration beginning July 1, 2020, providing insulin to eligible individuals with $30 monthly co-payment through participating pharmacies.

Creates Minnesota insulin patient assistance program administered by MNsure board, connecting eligible patients to insulin manufacturer assistance programs at no cost to patients.

Requires all pharmacies licensed in Minnesota to participate in emergency program as condition of doing business; requires insulin manufacturers to participate in patient assistance program and provide three-month initial supplies and 90-day reorders at no charge.

Establishes insulin assistance account funded by manufacturer registration fees (assessed based on market share of insulin units sold) to cover program costs and reimburse pharmacies and administrative expenses.

Caps cost-sharing for insulin in all health plans at $30 monthly maximum effective January 1, 2021; requires reporting to legislature annually on program participation and costs.